BGM Group Ltd. (NASDAQ:BGM) Sees Large Decrease in Short Interest

BGM Group Ltd. (NASDAQ:BGM) was the target of a large decrease in short interest in October. As of October 15th, there was short interest totaling 8,247 shares, a decrease of 92.6% from the September 30th total of 112,147 shares. Based on an average trading volume of 11,701 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.2% of the shares of the stock are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings cut BGM Group from a “sell (d)” rating to a “sell (e+)” rating in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, BGM Group currently has an average rating of “Sell”.

BGM Group Price Performance

NASDAQ BGM traded up $0.55 on Monday, hitting $8.40. The company had a trading volume of 10,751 shares, compared to its average volume of 12,149. The company’s fifty day moving average price is $8.42 and its 200-day moving average price is $22.33. BGM Group has a 12-month low of $6.45 and a 12-month high of $302.40.

BGM Group (NASDAQ:BGM) last posted its quarterly earnings data on Friday, August 28th. The company reported ($0.30) earnings per share (EPS) for the quarter. The business had revenue of $12.15 million for the quarter.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.